Now on ScienceBlogs: And so, driven on ceaselessly toward new shores
Molecules: You'd better learn to live with them.
« Ribosomal Free Love | Main | Slentrol/Dirloapide (Got a fat dog?) »
Category: Drugs
Posted on: June 3, 2009 8:29 PM, by Molecule of the Day
A few months ago, a tyrosine kinase inhibitor anticancer drug for people, this month, one for dogs.
It is made to treat cutaneous mast cell tumors, which apparently account for about a quarter of dog cancers.
I know a lot of people drugs end up in pets, but do pet drugs ever end up crossing over into human medicine? Anyone know anything about how the decision to go after a dog-specific drug works? Just cheaper to go after?
Find more posts in: 
Medicine & Health
Life Science
TrackBack URL for this entry: http://scienceblogs.com/mt/pings/111575
PZ Myers 11.07.2009
Orac 11.06.2009
PZ Myers 11.07.2009
Orac 11.05.2009
revere 11.07.2009
Comments
There was a dog obesity drug that was created recently that failed when tested with humans but had passed animal tests with dogs first.
You are right that they probably would not try to create a cancer drug just for dogs.
Posted by: Hugo | June 4, 2009 9:28 AM
Since all human drugs are first tested in animals and only the ones effective there make it through, you could say that all human drugs are also "pet" drugs (if you consider rats, rabbits and monkeys as potential pets)
Posted by: mikka | June 6, 2009 3:32 PM